Adial Pharmaceuticals Inc

Historical 13F Holders

Symbol
ADIL
CUSIP
00688A304
All holders as of
Q2 2026
Type
Equity
Class
STOCK
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 00688A304 since 12/18/2024, newest first.

Filer % of Class Filed
Coastlands Capital LP 13G/A Amendment 1
14.2% 7/1/2026
Event 6/24/2026
Coastlands Capital LP 13G
10.0% 6/24/2026
Event 6/17/2026
Armistice Capital, LLC 13G/A Amendment 1
4.99% 5/15/2026
Event 3/31/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 17 136 k $335 k
2026 Q1 15 35.6 k $63.8 k
2025 Q4 1 2.09 k $460.00
2025 Q3 1 2.09 k $740.00
2025 Q2 1 2.09 k $633.00
2025 Q1 1 2.09 k $1.33 k
2024 Q4 1 2.09 k $2.11 k
2024 Q3 1 2.09 k $2.09 k
2024 Q2 1 2.09 k $2.41 k
2024 Q1 1 2.09 k $2.78 k
2023 Q4 1 2.09 k $3.89 k
2023 Q3 1 2.09 k $5.82 k
2023 Q2 1 52.3 k $10.9 k
2023 Q1 1 52.3 k $18.3 k
2022 Q4 1 52.3 k $11.3 k
2022 Q3 1 52.3 k $18.3 k
2022 Q2 1 52.3 k $70.1 k
2022 Q1 1 41.8 k $84.1 k
2021 Q4 1 41.8 k $113 k
2021 Q3 1 41.8 k $180 k
2021 Q2 1 41.8 k $107 k
2021 Q1 1 41.8 k $101 k
2020 Q4 1 41.8 k $71.1 k
2020 Q3 1 41.8 k $93.3 k
2020 Q2 1 41.8 k $58.2 k
2020 Q1 1 41.8 k $54.4 k
2019 Q4 1 41.8 k $101 k
2019 Q3 1 41.8 k $63.2 k
2019 Q1 1 41.8 k $144 k